Form 8-K - Current report:
SEC Accession No. 0000950170-25-089945
Filing Date
2025-06-25
Accepted
2025-06-25 16:05:28
Documents
10
Period of Report
2025-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K hlvx-20250623.htm   iXBRL 8-K 74895
  Complete submission text file 0000950170-25-089945.txt   181381

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hlvx-20250623.xsd EX-101.SCH 24829
12 EXTRACTED XBRL INSTANCE DOCUMENT hlvx-20250623_htm.xml XML 4691
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41365 | Film No.: 251073671
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)